论文部分内容阅读
目的 :对应用顺氯氨铂联合化疗合并放疗治疗晚期非小细胞肺癌的疗效进行评价。方法 :顺氯氨铂联合化疗加放疗 58例为实验组 ,单纯放疗 2 9例为对照组 ,观察并比较其疗效。结果 :实验组CR、CR +PR和PD分别为 55.2 % ( 32 /58)、65.5% ( 38/58)和 8.6% ( 5/58) ;对照组分别为 2 4 .1 % ( 7/2 9)、31 .0 % ( 9/2 9)和 4 4.8%( 1 3/2 9) ,两组比较差异有非常显著意义 (P <0 .0 1 ) ,实验组 1、2年生存率优于对照组 (P <0 .0 1及 <0 .0 5)。结论 :顺氯氨铂联合化疗加放疗有助于提高晚期非小细胞肺癌的疗效和生存率 ,值得在临床上推广
Objective : To evaluate the efficacy of cisplatin combined with chemotherapy combined with radiotherapy for advanced non-small cell lung cancer. Methods : Cisplatin combined with chemotherapy plus radiotherapy in 58 cases as the experimental group, radiotherapy alone in 29 cases as the control group, observed and compared the efficacy. Results: The CR, CR +PR, and PD in the experimental group were 55.2% (32/58), 65.5% (38/58), and 8.6% (5/58), respectively; the control group was 24.1% (7/2). 9), 31.0% (9/2 9) and 4 4.8% (1 3/2 9), the difference between the two groups was very significant (P < 0.01), and the 1-year and 2-year survival rates of the experimental group. Better than the control group (P <0 1 and <0 5). Conclusion : Cisplatin combined with chemotherapy and radiotherapy can improve the curative effect and survival rate of advanced non-small cell lung cancer. It is worthy of promotion in clinical practice.